rxstat › Drug prices › Sulfasalazine

Sulfasalazine (Salazopyrin, Salazopyrin En-Tabs) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Sulfasalazine 500 mg tablet costs about $0.18 to $0.20 per tablet on public drug plan price lists across 9 provinces, before the pharmacy's dispensing fee. The brand (Salazopyrin Tab 500mg) lists at $0.40.

Sulfasalazine has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formBCABSKMBONNBNSPENL
500 mg Tabletper tablet$0.20brand $0.40$0.18brand $0.37$0.18brand $0.37$0.18$0.18brand $0.37$0.18$0.18$0.18$0.20brand $0.40
500 mg Tablet (Enteric-Coated)per tablet$0.44brand $0.61$0.41brand $0.56$0.41brand $0.56–$0.39brand $0.56$0.39$0.41brand $0.55$0.41–
Plan coverageCoveredCoveredCoveredPrice listCoveredCoveredCoveredPrice listPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay. In Ontario, the plan pays only up to the lowest interchangeable price ($0.18 per tablet for 500 mg).

Listed products by province

British Columbia: 5 products
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · PMS
    DIN 00598461 · $0.20/tablet · Covered
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.20/tablet · Covered
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.40/tablet · Partly covered
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · PMS
    DIN 00598488 · $0.44/tablet · Covered
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · PFI
    DIN 02064472 · $0.61/tablet · Partly covered
Alberta: 5 products
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.18/tablet · Covered
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · PMS
    DIN 00598461 · $0.18/tablet · Covered
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.37/tablet · Not covered
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · PMS
    DIN 00598488 · $0.41/tablet · Covered
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · PFI
    DIN 02064472 · $0.56/tablet · Not covered
Saskatchewan: 5 products
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · PMS
    DIN 00598461 · $0.18/tablet · Covered
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.18/tablet · Covered
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.37/tablet · Covered
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · PMS
    DIN 00598488 · $0.41/tablet · Covered
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · PFI
    DIN 02064472 · $0.56/tablet · Covered
Manitoba: 1 product
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.18/tablet · Price list
Ontario: 5 products
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · Pharmascience Inc.
    DIN 00598461 · $0.18/tablet · Covered
  • Jamp Sulfasalazine 500 mg Tablet · Jamp Pharma Corporation
    DIN 02544652 · $0.18/tablet · Covered
  • Salazopyrin Tab 500mg 500 mg Tablet · Pfizer Canada Inc.
    DIN 02064480 · $0.37/tablet · Covered
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · Pharmascience Inc.
    DIN 00598488 · $0.39/tablet · Covered
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · Pfizer Canada Inc.
    DIN 02064472 · $0.56/tablet · Covered
New Brunswick: 5 products
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · PMS
    DIN 00598461 · $0.18/tablet · Covered
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.18/tablet · Covered
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.18/tablet · Covered
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · PMS
    DIN 00598488 · $0.39/tablet · Covered
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · PFI
    DIN 02064472 · $0.39/tablet · Covered
Nova Scotia: 5 products
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.18/tablet · Covered
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.18/tablet · Covered
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · PMS
    DIN 00598461 · $0.18/tablet · Covered
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · PMS
    DIN 00598488 · $0.41/tablet · Covered
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · PFI
    DIN 02064472 · $0.55/tablet · Covered
Prince Edward Island: 5 products
  • Pms-Sulfasalazine 500mg/Tab Usp 500 mg Tablet · PMS
    DIN 00598461 · $0.18/tablet · Price list
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.18/tablet · Price list
  • Jamp Sulfasalazine 500 mg Tablet · JPC
    DIN 02544652 · $0.18/tablet · Price list
  • Pms-Sulfasalazine-E.c. Tab 500mg 500 mg Tablet (Enteric-Coated) · PMS
    DIN 00598488 · $0.41/tablet · Price list
  • Salazopyrin En-Tabs 500 Mg 500 mg Tablet (Enteric-Coated) · PFI
    DIN 02064472 · $0.41/tablet · Price list
Newfoundland and Labrador: 2 products
  • Jamp Sulfasalazine 500 mg Tablet · JAM
    DIN 02544652 · $0.20/tablet · Price list
  • Salazopyrin Tab 500mg 500 mg Tablet · PFI
    DIN 02064480 · $0.40/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · BC PharmaCare Low Cost Alternative list (Nov 5, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · PEI Pharmacare Maximum Reimbursable Price List (Nov 24, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026) · Manitoba Drug Interchangeability Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 4
Reports on file
19

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
SALAZOPYRIN EN-TABS 500 MG
500MG · TABLET (ENTERIC-COATED) · PFIZER CANADA ULC
DIN 02064472 · ended Apr 3, 2023 · Demand increase for the drug.
Resolved
SALAZOPYRIN EN-TABS 500 MG
500MG · TABLET (ENTERIC-COATED) · PFIZER CANADA ULC
DIN 02064472 · ended Feb 14, 2023 · Demand increase for the drug.
Resolved
PMS-SULFASALAZINE-E.C. TAB 500MG
500MG · TABLET (ENTERIC-COATED) · PHARMASCIENCE INC
DIN 00598488 · ended Oct 21, 2022 · Disruption of the manufacture of the drug.
Resolved
PMS-SULFASALAZINE 500MG/TAB USP
500MG · TABLET · PHARMASCIENCE INC
DIN 00598461 · ended May 18, 2022 · Disruption of the manufacture of the drug.
Resolved
PMS-SULFASALAZINE-E.C. TAB 500MG
500MG · TABLET (ENTERIC-COATED) · PHARMASCIENCE INC
DIN 00598488 · ended Apr 28, 2022 · Disruption of the manufacture of the drug.
Resolved
SALAZOPYRIN TAB 500MG
500MG · TABLET · PFIZER CANADA ULC
DIN 02064480 · ended Apr 21, 2022 · Demand increase for the drug.
Resolved
SALAZOPYRIN TAB 500MG
500MG · TABLET · PFIZER CANADA ULC
DIN 02064480 · ended Apr 21, 2022 · Demand increase for the drug.
Resolved
PMS-SULFASALAZINE 500MG/TAB USP
500MG · TABLET · PHARMASCIENCE INC
DIN 00598461 · ended Mar 1, 2022 · Disruption of the manufacture of the drug.
Resolved
SALAZOPYRIN EN-TABS 500 MG
500MG · TABLET (ENTERIC-COATED) · PFIZER CANADA ULC
DIN 02064472 · ended Apr 14, 2021 · Demand increase for the drug.
Discontinued
PMS-SULFASALAZINE-E.C. TAB 500MG
500MG · TABLET (ENTERIC-COATED) · PHARMASCIENCE INC
DIN 00598488
Resolved
PMS-SULFASALAZINE-E.C. TAB 500MG
500MG · TABLET (ENTERIC-COATED) · PHARMASCIENCE INC
DIN 00598488 · ended Nov 4, 2019 · Demand increase for the drug.
Resolved
PMS-SULFASALAZINE 500MG/TAB USP
500MG · TABLET · PHARMASCIENCE INC
DIN 00598461 · ended Jul 10, 2019 · Shortage of an inactive ingredient or component.

Showing 12 of 19 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Sulfasalazine. Health Canada has 19 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Sulfasalazine is classified under “INTESTINALANTIINFLAMMATORY AGENTS” (ATC A07EC).

Recent changes

Common questions

How much does Sulfasalazine cost in Canada?

Sulfasalazine 500 mg tablet costs about $0.18 to $0.20 per tablet on public drug plan price lists across 9 provinces, before the pharmacy's dispensing fee. The brand (Salazopyrin Tab 500mg) lists at $0.40.

Is Sulfasalazine covered by provincial drug plans?

On the public plans' own lists: British Columbia: covered; Alberta: covered; Saskatchewan: covered; Manitoba: price list; Ontario: covered; New Brunswick: covered; Nova Scotia: covered; Prince Edward Island: price list; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Sulfasalazine be back in stock in Canada?

Sulfasalazine has no active shortage; supply is normal per Health Canada reports.

Why is Sulfasalazine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (intestinalantiinflammatory agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.